During the treatment process, the risk of MVI in patients is assessed preoperatively by deTECsting the TM4SF1 expression level, so as to develop a more precise surgical plan; in the postoperative period, the use of TM4SF1 inhibitors can prevent tumor recurrence. Here, TM4SF1 is linked to neoplasm.